Cellular Therapy Tracking Global Market Report 2025
상품코드:1855819
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 250 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
세계의 세포 치료 추적 시장 규모는 최근 급속히 확대되고 있습니다. 2024년 25억 6,000만 달러에서 2025년에는 29억 달러에 달하고, CAGR 13.3%로 확대될 것으로 보입니다. 이 실적기간의 성장은 재생의료의 임상시험 증가, 개별화의료를 중시하는 인식 상승, 학계와 산업계의 협력관계의 확대, 세포치료의 효능과 안전성에 대한 인식의 상승, 세포 및 유전치료 기업에 대한 투자와 벤처캐피탈 증가 등에 관련되어 있다고 생각됩니다.
세포 치료 추적 시장 규모는 향후 수년간 급성장할 것으로 전망됩니다. 2029년까지 CAGR 12.9%로 47억 1,000만 달러로 성장할 것으로 보입니다. 이 예측기간 중 성장은 개별화의료나 정밀의료의 보급, 세포 및 유전자 치료의 파이프라인 증가, 임상시험이나 규제 당국의 승인 증가, 만성 질환이나 희귀질환의 이환율 증가, 세포 치료 제조 능력의 확대 등에 관련하고 있습니다. 예측 기간 동안의 주요 동향으로는 세포 치료 추적과 디지털 건강 플랫폼의 통합, 세포 연구에서 바이오인포매틱스의 이용, 세포 치료 연구의 진보, 규제 준수 툴의 강화, AI와 머신러닝의 도입 등이 있습니다.
세포 치료 추적 시장의 성장은 특히 환자 특유의 세포 모니터링 및 규제 기준 준수에 대한 수요 증가로 인한 맞춤형 의료 사용 증가로 인한 것입니다. 맞춤형 의료는 개인의 유전자 프로파일, 라이프 스타일, 환경에 따라 치료와 예방을 사용자 정의하는 방법입니다. 이 변화는 유전적 돌연변이의 정확한 식별과 맞춤형 치료의 창출을 가능하게 하는 유전체학의 진보에 크게 뒷받침됩니다. 세포 치료 추적은 치료를 통해 환자 특정 세포의 정확한 모니터링과 관리를 보장함으로써 맞춤형 의료를 지원하는 데 중요한 역할을합니다. 세포 치료 추적은 추적성, 규정 준수 및 건강 관리 제공업체의 효율적인 워크플로우를 제공하여 치료의 안전과 효과를 향상시킵니다. 예를 들어, 2024년 2월 맞춤형 의료연합(PMC)은 미국 식품의약국(FDA)이 2023년에 26개의 새로운 개인화 의약품을 승인했다고 보고했습니다(2022년에는 12개). 이러한 맞춤형 의료 도입 증가는 세포 치료 추적 시장의 성장을 가속하고 있습니다.
세포 치료 추적 시장의 주요 기업들은 추적성, 규제 준수, 환자의 안전성을 보장하기 위해 COI(Chain of Identity) 관리 시스템 등의 확장 가능한 플랫폼 구축에 주력하고 있습니다. 이 COI 관리 플랫폼은 치료 과정 전반에 걸쳐 환자 고유의 세포 동일성을 추적하고 검증하는 디지털 시스템입니다. 예를 들어, 2023년 5월 영국 소프트웨어 회사인 TrakCel Limited는 OCELLOS 제품군의 일부인 OCELLOS Core를 출시했습니다. OCELLOS Core는 초기 단계의 자기 및 개인화된 세포 및 유전자 치료(CGT) 임상시험을 위한 COI 관리 플랫폼으로 설계되었습니다. 이 플랫폼은 자동화된 COI 추적을 제공하여 최초 등록부터 정확한 환자 기록을 보장합니다. 이 시스템은 사전 설정되고 검증되었으므로 2-3주간 도입이 가능하며, 치료가 임상시험에서 상업화로 진행됨에 따라 비용 효율적인 확장성을 제공합니다. 또한 완벽한 감사 추적으로 Chain of Custody 이벤트를 추적하여 컴플라이언스 및 협업을 개선합니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 세포 치료 추적 시장 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 이용 산업의 분석
세계의 세포 치료 추적 시장 : 성장률 분석
세계의 세포 치료 추적 시장 실적 : 규모와 성장, 2019-2024년
세계의 세포 치료 추적 시장 예측 : 규모와 성장, 2024-2029년, 2034F
세계의 세포 치료 추적 : 총 시장 규모(TAM)
제6장 시장 세분화
세계의 세포 치료 추적 시장 : 제품 유형별, 분석과 예측, 2019-2024년, 2024-2029F, 2034F
소프트웨어
서비스
세계의 세포 치료 추적 시장 : 용도별, 분석과 예측, 2019-2024년, 2024-2029F, 2034F
암
심혈관 질환
근골격계 질환
자가면역질환
기타 용도
세계의 세포 치료 추적 시장 : 최종 사용자별, 분석과 예측, 2019-2024년, 2024-2029F, 2034F
병원
연구기관
바이오테크놀러지 기업
기타 최종 사용자
세계의 세포 치료 추적 시장 : 소프트웨어 유형별 세분화, 분석과 예측, 2019-2024년, 2024-2029F, 2034F
환자 등록 소프트웨어
임상시험 관리 소프트웨어
전자 데이터 수집(EDC) 시스템
실험실 정보 관리 시스템(LIMS)
세포 치료 공급망 관리 소프트웨어
컴플라이언스 리포팅 소프트웨어
데이터 분석 및 시각화 도구
세계의 세포 치료 추적 시장 : 서비스 유형별 세분화, 분석과 예측, 2019-2024년, 2024-2029F, 2034F
구현 및 통합 서비스
교육 및 교육 서비스
컨설팅 서비스
매니지드 서비스
기술지원 및 유지보수
데이터 보안 및 컴플라이언스 서비스
제7장 지역별/국가별 분석
세계의 세포 치료 추적 시장 : 지역별, 분석과 예측, 2019-2024년, 2024-2029F, 2034F
세계의 세포 치료 추적 시장 : 국가별, 분석과 예측, 2019-2024년, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 프로파일
세포 치료 추적 시장 : 경쟁 구도
세포 치료 추적 시장 : 기업 프로파일
Johnson & Johnson : 개요, 제품 및 서비스, 전략 및 재무 분석
Novartis AG : 개요, 제품 및 서비스, 전략 및 재무 분석
Bristol-Myers Squibb Company : 개요, 제품 및 서비스, 전략 및 재무 분석
Thermo Fisher Scientific Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
Gilead Sciences Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
Merck KGaA
GE Healthcare Technologies Inc.
Becton Dickinson and Company
Lonza Group Ltd.
Nikon Corporation
Charles River Laboratories International Inc.
Sartorius AG
Bio-Rad Laboratories Inc.
Bio-Techne Corporation
Miltenyi Biotec BV & Co. KG
Promega Corporation
Vericel Corporation
Adaptimmune Therapeutics plc
Medipost Co. Ltd.
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
세포 치료 추적 시장(2029년) : 새로운 기회를 제공하는 국가
세포 치료 추적 시장(2029년) : 새로운 기회를 제공하는 부문
세포 치료 추적 시장(2029년) : 성장 전략
시장 동향에 기초한 전략
경쟁 전략
제36장 부록
JHS
영문 목차
영문목차
Cellular therapy tracking refers to the organized process of overseeing and managing the full lifecycle of cellular therapies, including cell collection, production, distribution, administration, and long-term patient monitoring. It maintains product quality, regulatory adherence, patient safety, and treatment success through comprehensive data recording and traceability. It also supports workflow optimization and ensures precise documentation throughout the therapy process.
The primary product categories in cellular therapy tracking are software and services. The software delivers digital platforms and tools to handle, observe, and organize information related to cell therapy activities and procedures. It is applied in areas such as cancer, cardiovascular conditions, musculoskeletal disorders, and more, serving end users including hospitals, research institutions, biotechnology companies, and others.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.
The cellular therapy tracking market research report is one of a series of new reports from The Business Research Company that provides cellular therapy tracking market statistics, including the cellular therapy tracking industry global market size, regional shares, competitors with the cellular therapy tracking market share, detailed cellular therapy tracking market segments, market trends, and opportunities, and any further data you may need to thrive in the cellular therapy tracking industry. This cellular therapy tracking market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The cellular therapy tracking market size has grown rapidly in recent years. It will grow from $2.56 billion in 2024 to $2.90 billion in 2025 at a compound annual growth rate (CAGR) of 13.3%. The growth in the historic period can be linked to an increase in clinical trials for regenerative medicine, heightened emphasis on personalized medicine, expansion of collaborations between academia and industry, greater awareness of cell therapy effectiveness and safety, and rising investments and venture capital in cell and gene therapy companies.
The cellular therapy tracking market size is expected to see rapid growth in the next few years. It will grow to $4.71 billion in 2029 at a compound annual growth rate (CAGR) of 12.9%. The growth in the forecast period can be linked to wider adoption of personalized and precision medicine, a growing pipeline of cell and gene therapies, an increase in clinical trials and regulatory approvals, higher incidence of chronic and rare diseases, and expansion of cell therapy manufacturing capabilities. Key trends during the forecast period include integration of cell therapy tracking with digital health platforms, use of bioinformatics in cellular research, advancements in cellular therapy studies, enhanced regulatory-compliance tools, and implementation of AI and machine learning.
The growth of the cellular therapy tracking market is being driven by the increasing use of personalized medicine, particularly due to the growing demand for patient-specific cell monitoring and adherence to regulatory standards. Personalized medicine is an approach that customizes treatment and prevention based on an individual's genetic profile, lifestyle, and environment. This shift is largely fueled by advancements in genomics, which allow for the precise identification of genetic variations and the creation of tailored treatments. Cellular therapy tracking plays a vital role in supporting personalized medicine by ensuring accurate monitoring and management of patient-specific cells throughout therapy. It enhances both the safety and effectiveness of treatments by offering traceability, regulatory compliance, and an efficient workflow for healthcare providers. For example, in February 2024, the Personalized Medicine Coalition (PMC) reported that the U.S. Food and Drug Administration (FDA) approved 26 new personalized medicines in 2023, compared to 12 in 2022. This increase in personalized medicine adoption is propelling the growth of the cellular therapy tracking market.
Key players in the cellular therapy tracking market are focusing on creating scalable platforms, such as chain of identity (COI) management systems, to ensure traceability, regulatory compliance, and patient safety. These COI management platforms are digital systems that track and verify the identity of patient-specific cells throughout the entire therapy process. For example, in May 2023, TrakCel Limited, a UK-based software company, launched OCELLOS Core, part of its OCELLOS suite, designed as a COI management platform for early-stage autologous and personalized cell and gene therapy (CGT) clinical trials. This platform offers automated COI tracking, ensuring accurate patient records from the initial enrollment. The system is pre-configured and validated, allowing deployment within two to three weeks and offering cost-effective scalability as therapies progress from clinical trials to commercialization. It also tracks chain of custody events with full audit trails, improving compliance and collaboration.
In June 2025, STEMCELL Technologies Inc., a biotechnology company based in Canada, acquired Cellular Highways Ltd. for an undisclosed amount. This acquisition allows STEMCELL Technologies to integrate Cellular Highways' advanced cell sorting technology into its offerings, enhancing the precision, scalability, and efficiency of cellular therapy manufacturing and tracking. Cellular Highways Ltd., a UK-based biotechnology firm, specializes in innovative cell sorting technologies for cellular therapy tracking.
Major players in the cellular therapy tracking market are Johnson & Johnson, Novartis AG, Bristol-Myers Squibb Company, Thermo Fisher Scientific Inc., Gilead Sciences Inc., Merck KGaA, GE Healthcare Technologies Inc., Becton Dickinson and Company, Lonza Group Ltd., Nikon Corporation, Charles River Laboratories International Inc., Sartorius AG, Bio-Rad Laboratories Inc., Bio-Techne Corporation, Miltenyi Biotec B.V. & Co. KG, Promega Corporation, Vericel Corporation, Adaptimmune Therapeutics plc, Medipost Co. Ltd., and TrakCel.
North America was the largest region in the cellular therapy tracking market in 2024. The regions covered in cellular therapy tracking report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the cellular therapy tracking market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The cellular therapy tracking market includes revenues earned by entities through logistics management, temperature-controlled shipping, chain of custody compliance, consulting and advisory support, cryopreservation, secure biostorage, end-to-end supply chain solutions, and quality assurance support. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Cellular Therapy Tracking Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on cellular therapy tracking market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for cellular therapy tracking ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The cellular therapy tracking market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Product Type: Software; Services
2) By Application: Cancer; Cardiovascular Diseases; Musculoskeletal Disorders; Autoimmune Diseases; Other Applications
3) By End-User: Hospitals; Research Institutes; Biotechnology Companies; Other End Users
Subsegments:
1) By Software: Patient Registry Software; Clinical Trial Management Software; Electronic Data Capture (EDC) Systems; Laboratory Information Management Systems (LIMS); Cell Therapy Supply Chain Management Software; Compliance And Reporting Software; Data Analytics And Visualization Tools
2) By Services: Implementation And Integration Services; Training And Education Services; Consulting Services; Managed Services; Technical Support And Maintenance; Data Security And Compliance Services
Companies Mentioned: Johnson & Johnson; Novartis AG; Bristol-Myers Squibb Company; Thermo Fisher Scientific Inc.; Gilead Sciences Inc.; Merck KGaA; GE Healthcare Technologies Inc.; Becton Dickinson and Company; Lonza Group Ltd.; Nikon Corporation; Charles River Laboratories International Inc.; Sartorius AG; Bio-Rad Laboratories Inc.; Bio-Techne Corporation; Miltenyi Biotec B.V. & Co. KG; Promega Corporation; Vericel Corporation; Adaptimmune Therapeutics plc; Medipost Co. Ltd.; TrakCel
3. Cellular Therapy Tracking Market Trends And Strategies
4. Cellular Therapy Tracking Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Cellular Therapy Tracking Growth Analysis And Strategic Analysis Framework
5.1. Global Cellular Therapy Tracking PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Cellular Therapy Tracking Market Growth Rate Analysis
5.4. Global Cellular Therapy Tracking Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Cellular Therapy Tracking Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Cellular Therapy Tracking Total Addressable Market (TAM)
6. Cellular Therapy Tracking Market Segmentation
6.1. Global Cellular Therapy Tracking Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Software
Services
6.2. Global Cellular Therapy Tracking Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Cancer
Cardiovascular Diseases
Musculoskeletal Disorders
Autoimmune Diseases
Other Applications
6.3. Global Cellular Therapy Tracking Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Research Institutes
Biotechnology Companies
Other End Users
6.4. Global Cellular Therapy Tracking Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Patient Registry Software
Clinical Trial Management Software
Electronic Data Capture (EDC) Systems
Laboratory Information Management Systems (LIMS)
Cell Therapy Supply Chain Management Software
Compliance And Reporting Software
Data Analytics And Visualization Tools
6.5. Global Cellular Therapy Tracking Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Implementation And Integration Services
Training And Education Services
Consulting Services
Managed Services
Technical Support And Maintenance
Data Security And Compliance Services
7. Cellular Therapy Tracking Market Regional And Country Analysis
7.1. Global Cellular Therapy Tracking Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Cellular Therapy Tracking Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
